Rapid resolution of severe disc new vessels in proliferative diabetic retinopathy following a single intravitreal injection of bevacizumab (Avastin)

A 70‐year‐old man with asymptomatic proliferative diabetic retinopathy received a single intravitreal injection of bevacizumab (Avastin). One month following treatment there was complete resolution of new vessels.

Saved in:
Bibliographic Details
Published inClinical & experimental ophthalmology Vol. 34; no. 8; pp. 802 - 803
Main Authors Isaacs, Timothy W, Barry, Chris
Format Journal Article
LanguageEnglish
Published Melbourne, Australia Blackwell Publishing Asia 01.11.2006
Subjects
Aged
Angiogenesis Inhibitors - therapeutic use
Antibodies, Monoclonal - therapeutic use
Antibodies, Monoclonal, Humanized
Bevacizumab
Diabetic Retinopathy - complications
Diabetic Retinopathy - drug therapy
Fluorescein Angiography
Humans
Injections
intravitreal injection
Male
new treatment
Optic Disk - blood supply
proliferative diabetic retinopathy
Retinal Neovascularization - drug therapy
Retinal Neovascularization - etiology
Vascular Endothelial Growth Factor A - antagonists & inhibitors
Vascular Endothelial Growth Factor A - immunology
Vitreous Body
Online AccessGet full text

Cover

More Information
Summary:A 70‐year‐old man with asymptomatic proliferative diabetic retinopathy received a single intravitreal injection of bevacizumab (Avastin). One month following treatment there was complete resolution of new vessels.
Bibliography:istex:D593AEB6BB8523596D7EB58D6058CC35F02BBAAF
ark:/67375/WNG-41DDLDS7-D
ArticleID:CEO1378
Photographic Essays
ISSN:1442-6404
1442-9071
DOI:10.1111/j.1442-9071.2006.01378.x